Stocks / Pharmaceuticals

TYRAPharmaceuticals

Tyra Biosciences, Inc.
$22.011d -18.1%5d -13.0%settled close · 2026-09-09
Mkt cap $2.0B (3/25)β 0.5352w $22–38Shares 53.9MInd. Pharmaceutical PreparationsNasdaq since 2021Emp. 87HQ Carlsbad, CAtyra.bio
Who’s talkingIdea Scout · free

Who’s talking about TYRA

No tracked investor commentary on TYRA yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 3 Nov 2026

Confirmed date · consensus EPS -0.70. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where TYRA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 15 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-09
2026-09-08
2026-09-04
2026-09-03
2026-09-02
2026-09-01
2026-08-21
2026-08-11
2026-08-05
2026-08-04
2026-07-20
2026-06-15
2026-06-11
2026-06-10
2026-06-09
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on TYRA is in this morning’s Brief. Get The Brief — $20/mo →